Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acri.Tec was a prominent German medical technology company that specialized in the development, production, and distribution of implants and consumables for ophthalmic surgery. Founded in 1997 and based in Hennigsdorf, Germany, the company gained international recognition for its pioneering work in micro-incision cataract surgery (MICS). Its core product line featured high-performance intraocular lenses (IOLs), including monofocal, multifocal, and toric varieties designed to be implanted through incisions smaller than two millimeters. In addition to lenses, Acri.Tec provided ophthalmic viscosurgical devices (OVDs) and specialized surgical instruments. The company was acquired by Carl Zeiss Meditec in 2007 to bolster Zeiss's surgical ophthalmology portfolio, and its technologies are now fully integrated into the Zeiss product ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acri.Tec.